Friday, 26 January - esou.uroweb.org · ESU course on Kidney Cancer Date 27 January 2018 Time 14.30...
Transcript of Friday, 26 January - esou.uroweb.org · ESU course on Kidney Cancer Date 27 January 2018 Time 14.30...
ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands
www.esou18.org
Friday, 26 January
08.30 - 08.40 Welcome Location: Plenary Room M. Brausi, Modena (IT)
08.40 - 09.00 Opening address The future of urology: The EAU perspective F. Debruyne, Arnhem (NL)
09.00 - 13.10 Prostate Cancer I: Diagnosis, pathology, screening, active surveillance Chairs: M. Brausi, Modena (IT) F. Debruyne, Arnhem (NL)
09.00 - 09.15 Reflex testing with serum, urine and tissue biomarkers: Which, when and how viable? B. Djavan, Vienna (AT)
09.15 - 09.20 Questions
09.20 - 09.35 Genetic testing in inherited prostate cancer A. Alcaraz, Barcelona (ES)
09.35 - 09.40 Questions
09.40 - 09.55 Morphologic basis of mpMRI prostate cancer evaluation F. Algaba, Barcelona (ES)
09.55 - 11.30 MRI imaging targeted prostate biopsy: Comparing 3 different techniques. Is there really a difference in results?
09.55 - 10.05 Fusion biopsy R. Sanchez Salas, Paris (FR)
10.05 - 10.15 In-bore biopsy M. Sedelaar, Nijmegen (NL)
10.15 - 10.25 Cognitive biopsy O. Rouviere, Lyon (FR)
10.25 - 10.45 Discussion with clinical cases J. Barentsz, Nijmegen (NL)
10.45 - 11.00 MRI in men on active surveillance for prostate cancer: The PRECISE recommendations C. Moore, London (GB)
11.00 - 11.15 Biopsy or monitoring patients with negative MRI J. Hugosson, Gothenburg (SE)
11.15 - 11.30 Discussion
11.30 - 12.00 Break
ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands
www.esou18.org
Friday, 26 January
12.00 - 12.15 How have recommendations against prostate cancer screening impacted the incidence and mortality of prostate cancer in the US
C. Evans, Sacramento (US)
12.15 - 12.25 Discussion
12.25 - 13.10 ROUND TABLE: Treatment modalities for intermediate risk prostate cancer: surgery vs hypofractionation RT vs focal therapy vs active surveillance
Chairs: J. Hugosson, Gothenburg (SE) A. Villers, Lille (FR) 12.25 - 12.33 Surgery S. Joniau, Leuven (BE)12.33 - 12.41 Hypofractionation RT C. Cozzarini, Milan (IT)12.41 - 12.49 Focal therapy A. Villers, Lille (FR)12.49 -12.57 Active surveillance M. Roobol, Rotterdam (NL)12.57 - 13.10 Discussion
13.10 - 14.00 Lunch
14.00 - 16.45 Renal cancer I: Localised: Alternative approaches for characterisation of renal tumours Chairs: P. Chlosta, Cracow (PL) A. Volpe, Novara (IT)
14.00 - 14.10 MRI J. Walz, Marseilles (FR)
14.10 - 14.20 Conventional and optical renal mass biopsy T. De Reijke, Amsterdam (NL)
14.20 - 14.30 Liquid biopsy M. von Brandenstein, Cologne (DE)
14.30 - 14.45 Discussion
14.45 - 15.00 The WHO ISUP classification of renal tumours: What has changed? G. Martignoni, Verona (IT)15.00 - 15.05 Discussion
15.05 - 15.30 Treatment of renal cancer in the elderly (>75years) Chairs: A. Minervini, Florence (IT) H. Van Poppel, Leuven (BE) 15.05 - 15.30 Is partial nephrectomy always the best choice for T1b tumours?15.05 - 15.15 Yes G. Janetschek, Salzburg (AT)15.15 - 15.25 No M. Kuczyk, Hanover (DE)15.25 - 15.30 Discussion
ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands
www.esou18.org
Friday, 26 January
15.30 - 16.00 DEBATE: Clamped vs. unclamped partial nephrectomy (open, lap. robotic)
15.30 - 15-40 Clamped P. Chlosta, Cracow (PL)
15.40 - 15.50 Unclamped M. Gallucci, Rome (IT)
15.50 - 16.00 Discussion
16.00 - 16.30 Panel discussion of clinical cases: Localised RCC Chair: P. Mulders, Nijmegen (NL) Panelists: A. Breda, Barcelona (ES) G. Stewart, Cambridge (GB) H. Van Poppel, Leuven (BE) J. Walz, Marseilles (FR)
16.30 - 16.45 Surveillance after nephrectomy: On the way towards evidence based protocols A. Bex, Amsterdam (NL)
16.45 - 17.15 Break
17.15 - 18.50 Controversial subjects on bladder cancer The role of extended lymphadenectomy for bladder cancer Chairs: G. Thalmann, Berne (CH) E. Xylinas, Paris (FR)
17.15 - 17.25 The American perspective C. Evans, Sacramento (US)
17.25 - 17.35 European perspective R. Hautmann, Neu-Ulm (DE)
17.35 - 17.45 Discussion
17.45 -18.10 Robotic assisted radical cystectomy: Always the right urinary diversion?17-45 - 17.55 No G. Thalmann, Berne (CH)17.55 - 18.05 Yes H. Van Der Poel, Amsterdam (NL)18.05 - 18.10 Discussion
18.10 - 18.50 Is there a role for local treatment in metastatic disease?18.10 - 18.20 The urologist perspective A. Stenzl, Tubingen (DE)18.20 - 18.30 The medical oncologist perspective A. Necchi, Milan (IT)18.30 - 18.40 Discussion
ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands
www.esou18.org
Saturday, 27 January
08.30 – 11.30 Prostate cancer II: Locally advanced Location: Plenary Room Chairs: A. Alcaraz, Barcelona (ES) S. Joniau, Leuven (BE)
08.30 – 08.45 Tools for detection of node metastasis: PSMA guided surgery T. Maurer, Munich (DE)
08.45 – 09.40 Management of loco-regional recurrence after definitive treatment
08.45 – 09.00 Cryoablation B. Malavaud, Toulouse (FR)
09.00 – 09.15 Salvage radiation therapy A. Bossi, Villejuif (FR)
09.15 - 09.30 Salvage radical prostatectomy – Robotic H. Van Der Poel, Amsterdam (NL)
09.30 - 09.40 Discussion
09.40 – 10.20 DEBATE: Reappraisal of neoadjuvant therapy for high and very high-risk PCA
09.40 – 09.55 Yes - it does make sense A. Volpe, Novara (IT)
09.55 - 10.10 No - it is useless N. Mottet, Saint Etienne (FR)
10.10 – 10.20 Discussion
10.20 – 11.00 Is lymph node dissection necessary in prostate cancer?
10.20 - 10.35 The American view C. Evans, Sacramento (US)
10.35 – 10.50 The European view M. Graefen, Hamburg (DE)
10.50 - 11.00 Discussion
11.00 - 11.30 Break
11.30 - 12.20 Penile cancer Reducing treatment aggressiveness without impairing outcomes Chairs: B. Ayres, London (GB) D. Pfister, Cologne (DE)
11.30 – 11.40 Conservative surgery for penile cancer: Indications and techniques S. Minhas, London (GB)
11.40 - 11.45 Discussion
ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands
www.esou18.org
Saturday, 27 January
11.45 – 11.55 From radical inguinal lymph node dissection to sentinel lymph node dissection for penile cancer B. Ayres, London (GB)
11.55 – 12.00 Discussion
12.00 - 12.10 Evolution of surgical techniques in testis cancer D. Pfister, Cologne (DE)
12.10 - 12.20 Discussion
12.20 – 14.10 Urothelial cancer II: Non muscle invasive bladder cancer Chairs: J. Catto, Sheffield (GB) J. Palou, Barcelona (ES)
12.20 - 12.30 New techniques for bladder tumour resection: Are they better than conventional TURBT? U. Nagele, Hall (AT)
12.30 - 12.35 Discussion
12.35 – 12 45 Complications of TURBT A. Masson-Lecomte, Creteil (FR)
12.45 - 12.50 Discussion
12.50 - 13.00 Socio-economic impact of BCG shortage M. Colombel, Lyon (FR)
13.00 – 13.05 Discussion
13.05 - 13.15 Genomic classification of non muscle invasive bladder tumours J. Catto, Sheffield (GB)
13.15 – 13.20 Discussion
13.20 – 13.30 New diagnostic tools for upper urinary tract TCC A. Breda, Barcelona (ES)
13.30 – 13.35 Discussion
13.35 – 14.10 Panel discussion – Second opinion in difficult clinical cases Chair: M. Babjuk, Prague (CZ) Panelists: J. Catto, Sheffield (GB) M. Colombel, Lyon (FR) J. Palou, Barcelona (ES) E. Xylinas, Paris (FR)
ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands
www.esou18.org
Sunday, 28 January
09.00 - 10.30 Prostate cancer III: Advanced and metastatic disease Location: Plenary Room Chairs: G. Janetschek, Salzburg (AT) H. Van Der Poel, Amsterdam (NL)
09.00 - 09.15 Open vs robotic surgery for locally advanced prostate cancer: Oncological and functional outcomes P. Gontero, Turin (IT)
09.15 - 09.20 Discussion
09.20 - 10.00 New trends for treatment of oligo metastatic prostate cancer
09.20 - 09.30 Radical prostatectomy M. Brausi, Modena (IT)
09.30 - 09.40 Radiotherapy B. Jereczek-Fossa, Milan (IT)
09.40 - 09.50 Chemo-hormone therapy N. Mottet, Saint Etienne (FR)
09.50 - 10.00 Discussion
10.00 - 10.30 Salvage LND after radical prostatectomy for PSA recurrence: An up-date
10.00 - 10.10 Robotic (Video) N. Suardi, Milan (IT)
10.10 - 10.20 Open (Video) S. Joniau, Leuven (BE)
10.20 - 10.30 Discussion
10.30 - 11.00 Break
11.00 - 12.00 The best of uro-oncology in 2017 Chairs: A. Breda, Barcelona (ES) M. Sedelaar, Nijmegen (NL)
11.00 - 11.15 Prostate cancer P. Ghadjar, Berlin (DE)
11.15 - 11.30 Renal cancer E. Linares Espinos, Madrid (ES)
11.30 - 11.45 Urothelial cancer A. Noon, Sheffield (GB)
11.45 - 12.00 Testis and penile cancer M. Salagierski, Zielona Gora (PL)
ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands
www.esou18.org
Sunday, 28 January
12.00 - 13.30 Renal cancer II: Locally advanced and metastatic Chairs: S. Brookman May, Munich (DE) O. Rodriguez Faba, Barcelona (ES)
12.00 - 12.15 The role of neoadjuvant and adjuvant therapy in kidney cancer A. Bamias, Athens (GR)
12.15 - 12.20 Discussion
12.20 - 12.35 Cytoreductive nephrectomy for metastatic RCC in the targeted therapy era V. Matveev, Moscow (RU)
12.35 - 12.40 Discussion
12.40 -12.55 The revival of immunotherapy in RCC and novel clinical trials A. Necchi, Milan (IT)
12.55 - 13.00 Discussion
13.00 - 13.30 Clinical case discussion Chair: A. Bamias, Athens (GR) Panelists: A. Bex, Amsterdam (NL) E. Linares Espinos, Madrid (ES) V. Matveev, Moscow (RU) A. Necchi, Milan (IT) O. Rodriguez Faba, Barcelona (ES)
13.30 - 13.35 Closing remarks M. Brausi, Modena (IT)
ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands
www.esou18.org
ESU/ESUI Hands-on Training in prostate MRI reading for urologists
Date 27 January 2018Time 14.30 - 18.00Room Hamburg, Passenger TerminalChair V. Kasivisvanathan, London (GB)Faculty J. Barentsz, Nijmegen (NL) V. Kasivisvanathan, London (GB) V. Panebianco, Rome (IT) F. Sanguedolce, Barcelona (ES)
14.30 - 14.40 The importance of prostate MRI to the urologist: Overview of the course V. Kasivisvanathan, London (GB)
14.40 - 15.10 Introduction to MRI sequences, scoring systems, PI-RADS J. Barentsz, Nijmegen (NL)
15.10 - 15.35 Interactive case discussion – reporting MRI using PI-RADS V. Panebianco, Rome (IT)
15.35 - 15.45 Treatment implications of an mpMRI-driven diagnostic pathway F. Sanguedolce, Barcelona (ES)
15.45 - 15.50 Introduction to the MIM software for MRI interpretation V. Kasivisvanathan, London (GB)
15.50 - 16.35 Assessment: Hands - on baseline assessment of MRI interpretation Supervised by Faculty
16.35 - 16.50 Review of assessment scans J. Barentsz, Nijmegen (NL)
16.50 - 17.35 Assessment: Hands - on baseline assessment of MRI interpretation Supervised by Faculty
17.35 - 17.50 Review of assessment scans V. Panebianco, Rome (IT)
17.50 - 18.00 Close
Registration fee: € 40 (excluding VAT)Limited places available – For further information please go to the registration desk.
ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands
www.esou18.org
ESU course on Kidney Cancer
Date 27 January 2018Time 14.30 – 17.30Room Matterhorn, Movenpick HotelChair J. Walz, Marseille (FR)
14.30 – 14.35 European School of Urology: A unique possibility for urological education J. Walz, Marseille (FR)
14.35 – 14.40 Introduction and aims J. Walz, Marseille (FR)
14.40 – 15.00 Diagnosis, biopsy and staging of kidney cancer J. Walz, Marseille (FR)
15.00 - 15.15 Management and treatment of kidney cancer
15.00 – 15.15 How to plan a surgical procedure and how to estimate surgical risk Speaker: B. Challacombe, London (GB)
15.15 - 16.04 Videos on how I do it:
15.15 – 15.25 Radical nephrectomy A. Bex, Amsterdam (NL)
15.25- 15.35 Partial nephrectomy B. Challacombe, London (GB)
15.35 – 15.45 Focal therapy J. Walz, Marseille (FR)
15.45 – 15.55 Active surveillance A. Minervini, Florence (IT)
15.55 – 16.05 Discussion
16.05 – 16.20 Break
16.20 – 16.50 Round table on how to avoid and manage complications Bleeding, Prolonged ischemia, Decreased renal function, Urinary and vascular fistulae Panel: A. Bex, Amsterdam (NL) B. Challacombe, London (GB) A. Minervini, Florence (IT) J. Walz, Marseille (FR)
16.50 – 17.05 Factors influencing functional and oncological outcome of kidney cancer treatment A. Minervini, Florence (IT)
17.05 – 17.25 Medical treatment of kidney cancer: “neoadjuvant” treatment of localized and advanced disease, Adjuvant treatment of kidney cancer, Treatment
of metastatic disease A. Bex, Amsterdam (NL)
17.25 - 17.30 Discussion and close
This course is available free to all delegates: No registration necessary.